Opinion on Central Nervous System

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Pfizer strikes in the battle for the US Alzheimer's market

Published By Datamonitor
28 Sep 2000
Expert View
Expert View

Making the most of new indications

Published By Datamonitor
29 Sep 2000
CommentWire
CommentWire

UCB: winning European market with novel anti-epileptic?

Published By Datamonitor
05 Oct 2000
CommentWire
CommentWire

Cephalon/Anesta: painful times could be ahead

Published By Datamonitor
12 Oct 2000
CommentWire
CommentWire

Pfizer: more pressure on inhaled insulins

Published By Datamonitor
16 Oct 2000
CommentWire
CommentWire

Biogen champions a new indication for Avonex

Published By Datamonitor
19 Oct 2000
CommentWire
CommentWire

Johnson and Johnson: antipsychotic proves its worth

Published By Datamonitor
26 Oct 2000
CommentWire
CommentWire

ADHD: NICE ruling for Ritalin, but will it boost sales?

Published By Datamonitor
02 Nov 2000
Expert View
Expert View

Compliance is just a click away

Published By Datamonitor
03 Nov 2000
CommentWire
CommentWire

Multiple sclerosis: NICE to reconsider decision

Published By Datamonitor
09 Nov 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.